The Weight of Bias: How GLP 1s Expose the Dark Side of Hiring Practices Recent research on GLP 1 medications has shown a 27 percentage point increase in employment for unemployed women after taking these weight loss drugs, raising questions about who has access to these treatments and what this means for the broader social and economic landscape.
Economist Rebecca Diamond's study sheds new light on the "female obesity penalty," which already paints a dismal picture: obese women face reduced earnings, lower marriage rates, and fewer opportunities.
However, her research reveals that GLP 1s can change this reality by significantly increasing employment rates among unemployed women over 18 months.